Fundraising FoxVively
2 known investors
Find your way into Vively
Sign up to see every warm intro you have to Vively
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vively team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vively offers preventative healthcare in Australia through comprehensive blood testing (60-100+ biomarkers), continuous glucose monitoring, and wearable and lifestyle data, paired with practitioner support. Its app and programs help members identify health risks early and follow personalised plans built by dietitians, nurses, and other practitioners to improve metabolic, hormonal, and other health markers over time.
Founders & leadership
Investors · 2
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$3.1M disclosed across 2 rounds · 2022–2025
- $1.6MseedMay 2025 · 3 sources
Archangel Ventures (lead), Bupa Ventures
Source ↗ - $1.5Mpre-Seed roundDec 2022 · 2 sources
Archangel Ventures (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Vively do?
- Vively offers preventative healthcare in Australia through comprehensive blood testing (60-100+ biomarkers), continuous glucose monitoring, and wearable and lifestyle data, paired with practitioner support. Its app and programs help members identify health risks early and follow personalised plans built by dietitians, nurses, and other practitioners to improve metabolic, hormonal, and other health markers over time.
- Who founded Vively?
- Vively was founded by Tim Veron.
- Who are Vively's investors?
- Vively's investors include Archangel Ventures.
- How much funding has Vively raised?
- Vively has disclosed $3.1M raised across 2 rounds.